GnRH Analogues in Reproduction and Gynecology : Volume II
These four volumes comprlslng "GnRH Analogues in Cancer and Human Reproduction" are a distillation of the presentations of the invited speakers at a landmark International Symposium bearing the same name, organized by one of us (B. L. ) and held in Geneva, SwitLerland in February 1988. The Symposium was truly interdisciplinary spanning gonadal hormone dependent disease including various forms of cancer and ranging to control of fertility, both pro- and conception. The international flavor can be caught from the 480 participants and 259 contributors drawn from 14 countries. The Symposium, and therefore this book, would not have been possible without the backing of The International Commitlee for Research in Reproduction and the sponsorship of the International Society of Gynecologic Endocrinology, The Swiss Society of fertility and Sterility, The University of Geneva School of Medicine, The Swiss Society of Endocrinology and The US foundation for Studies in Reproduction Inc. , and help from the World Health Organization. B. H. Vickery B. Lunenfeld June 1989 xiii LIST OF CONTRIBUTORS TO THE SERIES A. Abbondante H. Bartermann First Institute of Obstetrics and Urologische Universitatsklinik Kiel Gynecology Arnold-Heller Strasse 7 University "La Sapienza" D-2300 Kiel 1, FRG Rome, Italy M. Bartholomew P. Abel Department of Medicine/Endocrinology Department of Urology Milton S. Hershey Medical Center Hammersmith Hospital Pennsylvania State University DuCaneRoad PO Box 850, Hershey, PA 17033, USA London W12 OHS, UK D. Beck H.
- Hardback | 256 pages
- 01 May 1990
- Dordrecht, Netherlands
- 1990 ed.
- 256 p.
Table of contents
1 Is there a rationale for GnRH analogue therapy in endometriosis?.- 2 GnRH agonists in the management of endometriosis: the results of two randomized trials.- 3 Comparison of buserelin to danazol therapy in endometriosis.- 4 LHRH agonist treatment of endometriosis.- 5 A Phase III clinical trial of buserelin versus danazol in the treatment of endometriosis.- 6 Management of pelvic endometriosis with a GnRH analogue.- 7 The use of GnRH analogues to control menstrual bleeding.- 8 Rationale, indications and management of GnRH analogues in ovulation induction protocols.- 9 Physiologic effects of a gonadotropin releasing hormone antagonist in normal women.- 10 Pharmacologic hypogonadotropism can be used to advantage for ovulation induction protocols.- 11 Induction of ovulation by combined GnRH-analogue/hMG/hCG treatment.- 12 Combined buserelin and exogenous gonadotropins in ovulation induction in infertile women with normal menstrual rhythm.- 13 Combined buserelin and exogenous gonadotrophin therapy for the treatment of infertility in women with polycystic ovarian disease.- 14 Comparison between short and long protocols using a combination of LHRH agonist and gonadotropins.- 15 Induction of ovulation with the combination of LHRH analog in a short protocol and exogenous gonadotropins.- 16 The use of GnRH analogues for synchronization of oocyte donation.- 17 Programmed oocyte retrieval for IVF: clinical and biological effects of different protocols of pituitary suppression and follicular stimulation.- 18 Improved pregnancy rate in IVF/ET by combined long-acting GnRH analog and gonadotropins.
`(These books) can be highly recommended; it should in fact be considered a serious lack if they are not present to complete the references on GnRH analogues.'
Annals of Oncology 2 (7) 1991
Annals of Oncology 2 (7) 1991